Recent research View all research
About Qrxpharma Limited
QRxPharma Limited (QRX) is a commercial-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management and central nervous system (CNS) disorders. The Company's product portfolio includes both late and early stage clinical drug candidates. QRX conducts its operations in Australia, with the main focus on MoxDuo (Morphine & Oxycodones) product.
Latest Qrxpharma Limited research